First Tracks Biotherapeutics, Inc. · NASDAQ:TRAX
Anaptysbio, Inc reported 1 trade in First Tracks Biotherapeutics, Inc. shares (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Anaptysbio, Inc (10% owner) reported 1 trade in First Tracks Biotherapeutics, Inc. shares, leaving 0 shares. Filed Apr 22, 2026 (Form 4).
- Shares
- 100 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock, par value $0.001 per share | Other | 100 | 0 | Direct |
Source
Related
- First Tracks Biotherapeutics, Inc.
- Anaptysbio, Inc
- First Tracks Biotherapeutics, Inc. shareholders
- Form 4 · Orwin John A · Sep 17, 2026
- Form 4 · Ware J. Anthony · Sep 4, 2026
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Affinity Asset Advisors, LLC · Aug 13, 2026